Products

Catalog #sort icon Name Size Storage Bio Cat. Status
03-001-050 Purified Interleukin-2 50 mL -70°C
03-020-050 Delectinized Interleukin-2 50 mL -70°C
07-210-001 Elutriated Human Adult Monocytes - Frozen - 2×10 1 mL -70°C
08-707-000 HIV-1IIIB Infected Cell DNA 100 µL -20°C
08-708-000 HIV-2NIH-Z Infected Cell DNA 100 µL -20°C
08-710-000 HTLV-IIC3-44/Mo Infected Cell DNA 100 µL -20°C
08-711-000 HTLV-IMT-2 Infected Cell DNA 100 µL -20°C
08-730-100 Adenovirus-2 Infected Cell DNA 100 µL -20°C
08-754-100 HPV-16 Transformed Cell DNA 100 µL -20°C
08-755-100 HPV-18 Transformed Cell DNA 100 µL -20°C
08-765-000 HHV-7H7-4 Infected Cell DNA 100 µL -20°C
08-921-000 HSV-1MacIntyre Quantitated Viral DNA 250 µL -20°C
08-922-000 HSV-2G Quantitated Viral DNA 250 µL -20°C
08-923-000 HHV-6BZ-29 Quantitated Viral DNA 250 µL -20°C
08-924-000 Neisseria gonorrhoeae Quantitated Bacterial DNA 250 µL -20°C
08-925-000 CMVAD169 Quantitated Viral DNA 250 µL -20°C
08-926-000 EBVB95-8 (Type 1) Quantitated Viral DNA 250 µL -20°C
08-927-000 VZVRod Quantitated Viral DNA 250 µL -20°C
08-931-000 Chlamydia trachomatis LGV-II434 Quantitated DNA 250 µL -20°C
08-932-250 Chlamydophila pneumoniaeCDC-CWL-011 Quantitated DNA 250 µL -20°C
08-938-250 KSHV/HHV-8KS-1 Quantitated Viral DNA 250 µL -20°C
08-940-250 VacciniaLister Quantitated Viral DNA 250 µL -20°C
08-942-250 BKVMM Quantitated Viral DNA 250 µL -20°C
08-943-250 JCVMAD1 Quantitated Viral DNA 250 µL -20°C
08-945-250 HHV-6AGS Quantitated Viral DNA 250 µL -20°C
08-946-250 Mycoplasma pneumoniae Quantitated DNA 250 µL -20°C
08-947-250 Adenovirus-5 Quantitated Viral DNA 250 µL -20°C
08-948-250 Toxoplasma gondiiRH Quantitated DNA 250 µL -20°C
08-949-250 Mycobacterium tuberculosis Quantitated Bacterial DNA 250 µL -20°C New ProductNew product
10-110-000 HSV-1MacIntyre Purified Virus 1 mg -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-111-000 HSV-2G Purified Virus 1 mg -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-112-000 HTLV-IMT-2 Purified Virus 1 mg -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-113-000 HTLV-IMT-2 Purified Viral Lysate 1 mg -70°C
10-115-000 EBVB95-8 (Type 1) Purified Virus 1 mg -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-118-000 HIV-1IIIB Purified Virus 1 mg -70°C ABiological Substance, Category A
UN 2814
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-119-000 HIV-1IIIB Purified Viral Lysate 1 mg -70°C
10-124-000 HIV-1IIIB Direct Pelleted Virus (1000X) 1 mL -70°C ABiological Substance, Category A
UN 2814
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-124-PNK HIV-1IIIB Direct Pelleted Virus (100X) 1 mL -70°C ABiological Substance, Category A
UN 2814
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-127-000 HIV-2NIH-Z Purified Virus 1 mg -70°C ABiological Substance, Category A
UN 2814
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. 		Discontinued - some remainingDiscontinued - some remaining
10-128-000 HIV-2NIH-Z Purified Viral Lysate 1 mg -70°C
10-144-000 CMVAD169 Purified Viral Lysate (1 mg/mL) 1 mg -70°C
10-144-PNK CMVAD169 Purified Viral Lysate (100 µg/mL) 1 mL -70°C
10-145-000 HSV-1MacIntyre Purified Viral Lysate 1 mg -70°C
10-146-000 HSV-2G Purified Viral Lysate 1 mg -70°C
10-147-000 EBVB95-8 (Type 1) Purified Viral Lysate 1 mg -70°C
10-149-000 SIVmac251 Purified Virus 1 mg -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-150-000 SIVmac251 Purified Viral Lysate 1 mg -70°C
10-152-000 SRV-1Macaque Purified Virus 1 mg -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. 		New ProductNew product
10-153-000 SRV-1Macaque Purified Viral Lysate 1 mg -70°C
10-177-000 HIV-1Ba-L Direct Pelleted Virus (500X) 1 mL -70°C ABiological Substance, Category A
UN 2814
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-183-000 CMVAD169 Direct Pelleted Virus (1000X) 1 mL -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. 		Call for availabilityCall for availability
10-201-500 Human Influenza A/Hong Kong/8/68 Purified Virus (H3N2) 0.5 mg -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-210-500 Human Influenza A/PR/8/34 Purified Virus (H1N1) 0.5 mg -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-218-000 SRV-2 Purified Virus 1 mg -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-220-500 Human Influenza B/Lee/40 Purified Virus 0.5 mg -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-223-000 SRV-5 Purified Virus 1 mg -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-226-000 HIV-1pHXB2D Direct Pelleted Virus (500X) 1 mL -70°C ABiological Substance, Category A
UN 2814
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-228-000 HIV-1pHXB2DDirect Pelleted Virus (1000X) 1 mL -70°C ABiological Substance, Category A
UN 2814
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-241-500 HHV-6AGS Purified Viral Lysate 0.5 mg -70°C
10-247-000 RSVA-2 Purified Virus (1 mg/mL) 1 mg -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-247-PNK RSVA-2 Purified Virus (100 µg/mL) 1 mL -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-248-000 RSVA-2 Purified Viral Lysate (1 mg/mL) 1 mg -70°C
10-248-PNK RSVA-2 Purified Viral Lysate (100 µg/mL) 1 mL -70°C
10-249-000 RSVA-2 Direct Pelleted Virus (1000X) 1 mL -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. 		Call for availabilityCall for availability
10-250-000 FeLVThielen Purified Virus 1 mg -70°C
10-252-000 VacciniaLister Purified Virus 1 mg -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-253-000 VacciniaLister Purified Virus, UV-Inactivated 1 mg -70°C
10-254-000 VacciniaWR Purified Virus 1 mg -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-255-000 VacciniaWR Purified Virus, UV-Inactivated 1 mg -70°C
10-259-000 Human Influenza A/2/Japan/305/57 Purified Virus (H2N2) 1 mg -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-262-000 Neisseria gonorrhoeae Viable Cells 1 mL -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-263-000 Neisseria gonorrhoeae Heat-Inactivated Cells 1 mL -70°C
10-264-000 Chlamydia trachomatis LGV-II434 Viable Purified Elementary Bodies 1 mL -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-265-000 Chlamydia trachomatis LGV-II434 Heat-Inactivated Elementary Bodies 1 mL -70°C Call for availabilityCall for availability
10-266-000 Adenovirus-5 Purified Virus 1 mg -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-267-500 Human Influenza A/PR/8/34 Purified Virus Inactivated with β-Propiolactone 0.5 mg -70°C New ProductNew product
10-268-500 Human Influenza A/New Caledonia/20/99 Purified Virus (H1N1) 0.5 mg -70°C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. 		New ProductNew product
10-270-000 RubellaHPV77 Purified Virus, UV-Inactivated 1 mg -70°C New ProductNew product
10-273-500 Human Influenza A/PR/8/34 Purified Virus, UV-Inactivated 0.5 mg -70°C New ProductNew product
10-275-500 CMVAD169 Purified Virus, B-PL Inactivated 0.5 mg -70°C New ProductNew product
10-276-000 Human Influenza A/2/Japan/305/57 (H2N2) Purified Virus, UV-Inactivated 1.0 mg -70°C New ProductNew product
10-501-001 EBVP3HR1 Inactivated Cell Extract 1 mL -70°C
10-501-025 EBVP3HR1 Inactivated Cell Extract 25 mL -70°C
10-502-001 EBVP3HR1 Viral Capsid Antigen, Immunoaffinity Purified 1 mL -70°C
10-502-025 EBVP3HR1 Viral Capsid Antigen, Immunoaffinity Purified 25 mL -70°C
10-505-001 HFS Uninfected Cell Extract 1 mL -70°C
10-508-001 Vero Uninfected Cell Extract 1 mL -70°C
10-514-001 VZVRod Inactivated Cell Extract 1 mL -70°C
10-514-025 VZVRod Inactivated Cell Extract 25 mL -70°C
10-515-001 HSV-1MacIntyre Inactivated Cell Extract 1 mL -70°C Call for availabilityCall for availability
10-515-025 HSV-1MacIntyre Inactivated Cell Extract 25 mL -70°C Call for availabilityCall for availability
10-516-001 HSV-2G Inactivated Cell Extract 1 mL -70°C
10-516-025 HSV-2G Inactivated Cell Extract 25 mL -70°C
10-518-001 Rubeola/MeaslesEdmonston Inactivated Cell Extract 1 mL -70°C
10-518-025 Rubeola/MeaslesEdmonston Inactivated Cell Extract 25 mL -70°C
10-523-001 EBV Nuclear Antigen-1 (EBNA-1) Recombinant protein 1 mL -70°C
10-523-025 EBV Nuclear Antigen-1 (EBNA-1) Recombinant protein 25 mL -70°C
10-528-001 MOLT-3 Uninfected Cell Extract 1.0 mg -70°C New ProductNew product
10-529-001 HSB-2 Uninfected Cell Extract 1.0 mg -70°C New ProductNew product
10-601-001 Immunoassay Stabilizer 1 L 2 to 8°C Call for availabilityCall for availability
13-102-100 HIV-1 anti-p24 gag 100 µg -20°C
13-103-100 HIV-1 anti-p17 gag 100 µg -20°C
13-104-100 HIV-1 anti-gp41 env 100 µg -20°C Call for availabilityCall for availability
13-105-100 HIV-1 anti-gp120 env (aa 307-320) 100 µg -20°C
13-108-100 HIV-1 anti-gp120 env 100 µg -20°C
13-112-100 SIVmac251 anti-p27 gag (does not react w/HIV-1 or -2 proteins) 100 µg -20°C
13-113-100 SIVmac251 anti-p27 gag (cross reacts w/HIV-1 and -2 proteins) 100 µg -20°C
13-137-100 HIV-1 anti-p66/51 pol 100 µg -20°C
13-138-100 HHV-6A Early Protein p41/38 100 µg -20°C
13-139-001 HHV-6A Early Protein p41/38 (cell culture supernatant) 1 mL -20°C Call for availabilityCall for availability
13-150-100 EBV anti-(EA-R) protein p17 100 µg -20°C
13-203-000 HIV-1IIIB Rabbit anti-p24 Polyclonal .50 mL -20°C
13-204-000 HIV-1IIIB Rabbit anti-gp120 Polyclonal .50 mL -20°C
13-210-100 KSHV/HHV-8 MAb to ORF73 (anti-LNA-1) 100 µg -20°C
13-211-100 KSHV/HHV-8 MAb to ORF59 100 µg -20°C
13-212-100 KSHV/HHV-8 MAb to ORF K8.1 A/B 100 µg -20°C
13-213-100 KSHV/HHV-8 MAb to ORF K8.1 A 100 µg -20°C
13-214-050 KSHV/HHV-8 Rabbit antibody vIL-6 Polyclonal 50 µg -20°C
13-216-100 HHV-6A/B MAb to early Phosphoprotein p41 100 µg -20°C
13-217-001 HHV-6A MAb to gp82/105 (cell culture supernatant) 1 mL -20°C
13-218-100 HHV-6A/B MAb to gp116/64/54 100 µg -20°C
13-219-001 HHV-6A/B MAb to gp116/64/54 (cell culture supernatant) 1 mL -20°C Call for availabilityCall for availability
13-222-100 Rabbit anti-Vaccinia Polyclonal    100 µg -20°C
14-101-050 HIV-1IIIB p24 gag Purified Native Protein 50 µg -70°C
14-102-050 HIV-1IIIB gp120 Purified Native Glycoprotein 50 µg -70°C
14-103-050 HIV-1IIIB gp160 env Purified Native Glycoprotein 50 µg -70°C
14-108-050 HIV-1IIIB nef Recombinant Viral Protein 50 µg -70°C
14-109-050 HIV-1pHXB2 gp41 Recombinant Viral Protein 50 µg -70°C
14-110-050 HIV-2ST gp36 Recombinant Viral Protein 50 µg -70°C
14-126-050 HIV-1IIIB p24 Recombinant Viral Protein 50 µg -70°C
14-127-050 HIV-1IIIB gp160 Recombinant Viral Protein 50 µg -70°C
14-128-050 HIV-1IIIB p66 (Reverse Transcriptase) Recombinant Viral Protein 50 µg -70°C
14-129-050 HIV-1MN gp120 Recombinant Viral Protein 50 µg -70°C
15-301-000 HHV-6 IgG Antibody IFA Kit Kit 2 to 8°C
15-321-000 HHV-7 IgG Antibody IFA Kit Kit 2 to 8°C
15-330-000 KSHV/HHV-8 IgG Antibody IFA Kit Kit 2 to 8°C
15-401-000 HHV-6 IgG Antibody ELISA Kit Kit 2 to 8°C
15-501-000 KSHV/HHV-8 IgG Antibody ELISA Kit Kit 2 to 8°C